Molecular perturbations restrict potential for liver repopulation of hepatocytes isolated from non-heart-beating

Yuta Enami1, Brigid Joseph, Sriram Bandi

  • 1Marion Bessin Liver Research Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Abstract

Insights

Organs from non-heart-beating donors are viable for cell therapy, but molecular changes after death impact cell quality. Understanding these changes can improve donor cell utility.

Area of Science:

  • Regenerative Medicine
  • Molecular Biology
  • Organ Transplantation

Background:

  • Organs from non-heart-beating donors are valuable for cell therapy.
  • Understanding molecular changes post-mortem is crucial for optimizing cell viability.

Purpose of the Study:

  • To investigate molecular perturbations in non-heart-beating donor rat livers and isolated hepatocytes.
  • To assess the viability, engraftment, and proliferation of hepatocytes from non-heart-beating donors.

Main Methods:

  • Global gene expression profiling using Affymetrix microarrays.
  • Assessment of hepatic tissue integrity and hepatocyte viability.
  • Transplantation studies in dipeptidyl peptidase IV-deficient rats.

Main Results:

  • Liver tissue remained intact for over 24 hours post-mortem.
  • Differential gene expression observed at 4, 16, and 34 hours post-mortem, affecting pathways like oxidative phosphorylation and cell adhesion.
  • Viable hepatocytes were isolated up to 4 hours post-mortem, but with reduced yield and viability compared to heart-beating donors.
  • Hepatocytes from non-heart-beating donors showed inferior engraftment and proliferation post-transplantation.
  • Isolated hepatocytes exhibited greater molecular perturbations than corresponding liver tissue, impacting signaling pathways.

Conclusions:

  • Non-heart-beating donor liver tissue integrity is maintained post-mortem.
  • Molecular changes, particularly in isolated hepatocytes, impair cell viability and function.
  • Further research into these molecular changes can enhance the use of non-heart-beating donor organs for cell therapy.

Related Concept Videos